Epidemiology, health policy and outcomes
Karen Costenbader, MD, MPH
Brigham and Women's Hospital/ Harvard Medical School
BOSTON, MA, United States
Disclosure(s): Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Cabaletta: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Exagen Diagnostics: Grant/Research Support (Ongoing); Gilead: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing)
Sheng-Ming Dai, MD
Shanghai Sixth People’s Hospital
Shanghai, Shanghai, China
Disclosure information not submitted.
April Jorge, MD
Massachusetts General Hospital
Boston, MA, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Vanessa Kronzer, MD, MSc
Mayo Clinic
Rochester, MN, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Laura Plantinga, PhD, MSc (she/her/hers)
University of California, San Francisco
San Francisco, CA, United States
Disclosure information not submitted.
Rachel Robbins, MD (she/her/hers)
Walter Reed National Military Medical Center
Germantown, MD, United States
Disclosure information not submitted.
Abstract oral session.
Non-CME
Presenting Author: Laura Plantinga, PhD, MSc (she/her/hers) – University of California, San Francisco
Presenting Author: Vanessa Kronzer, MD, MSc – Mayo Clinic
Presenting Author: Karen Costenbader, MD, MPH – Brigham and Women's Hospital/ Harvard Medical School
Presenting Author: Rachel Robbins, MD (she/her/hers) – Walter Reed National Military Medical Center
Presenting Author: April Jorge, MD – Massachusetts General Hospital
Presenting Author: Sheng-Ming Dai, MD – Shanghai Sixth People’s Hospital